Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.34 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17206627 | 0.92 | KMT2A (0.42) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL9923860 | 0.87 | P2RX7 (0.40) | P2RX7ALDH1A1TSHRMAPK14MCHR1 | |
| SCHEMBL9924237 | 0.86 | SIGMAR1 (0.39) | ALDH1A1TSHRMAPK14MCHR1SIGMAR1 | |
| SCHEMBL17206625 | 0.86 | EPHX2 (0.43) | P2RX7SIGMAR1 | |
| SCHEMBL17206622 | 0.86 | EPHX2 (0.43) | P2RX7SIGMAR1 | |
| SCHEMBL9924243 | 0.85 | P2RX7 (0.39) | P2RX7ALDH1A1TSHRMAOBMAPK14 | |
| SCHEMBL9924241 | 0.85 | SSTR3 (0.40) | P2RX7ALDH1A1MAPK14MCHR1SSTR3 | |
| SCHEMBL9924429 | 0.84 | NTRK1 (0.43) | ALDH1A1SIGMAR1 | |
| SCHEMBL9924272 | 0.84 | P2RX7 (0.41) | P2RX7ALDH1A1MEN1KMT2AMCHR1 | |
| SCHEMBL9924239 | 0.83 | MAPK14 (0.36) | P2RX7MAPK14CES2CES1MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9169199-B2 | Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | LYCERA CORPORATION (US) | 2015-10-27 | — | — | US | disclosed |
| US-9169199-B2 | Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | LYCERA CORPORATION (US) | 2015-10-27 | — | — | US | disclosed |
| WO-2012078867-A2 | CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF | LYCERA CORPORATION (US) | 2012-06-14 | — | — | WO | disclosed |